Drug Database
L01FG01 bevacizumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Alymsys 25 mg/mL concentrate for solution for infusion ▼
- POM Avastin 25mg/ml concentrate for solution for infusion
- POM Aybintio 25 mg/ml concentrate for solution for infusion ▼
- POM Oyavas 25 mg/mL concentrate for solution for infusion ▼
- POM Oyavas 25 mg/mL concentrate for solution for infusion ▼
- POM Vegzelma 100mg concentrate for solution for infusion ▼
- POM Vegzelma 400mg concentrate for solution for infusion ▼
- POM Zirabev 25 mg/ml concentrate for solution for infusion (100 mg/4 ml) ▼
- POM Zirabev 25 mg/ml concentrate for solution for infusion (400 mg/16 ml) ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).